Validation study for genetic markers for growth hormone treatment in growth hormone deficient and turner syndrome patients

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-000460-10

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To confirm that at least one of the genetic markers associated to the amplitude of first year growth response to recombinant human growth hormone (r-hGH) treatment identified in PREDICT Long- Term Follow-Up (LTFU) Study (28614) is replicated in an independent population of this study of prepubertal children with either idiopathic growth hormone deficiency (IGHD) or Turner Syndrome (TS).


Critère d'inclusion

  • Idiopathic Growth Hormone Deficiency and Turner Syndrome